Related Experiment Video
Updated: Jan 21, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis
Christine L Barnett1,2, Matthew S Davenport3,4, Jeffrey S Montgomery4
1RTI Health Solutions, Research Triangle Park, North Carolina.
Abstract:
The objective of this study was to evaluate the cost-effectiveness of 18F-choline PET/multiparametric MRI (mpMRI) versus mpMRI alone for the detection of primary prostate cancer with a Gleason score of greater than or equal to 3 + 4 in men with elevated prostate-specific antigen levels. Methods: A Markov model of prostate cancer onset and progression was used to estimate the health and economic consequences of 18F-choline PET/mpMRI for the detection of primary prostate cancer with a Gleason score of greater than or equal to 3 + 4 in men with elevated prostate-specific antigen levels. Multiple simultaneous hybrid 18F-choline PET/mpMRI strategies were evaluated using Likert or Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) scoring; the first was biopsy for Likert 5 mpMRI lesions or Likert 3-4 lesions with 18F-choline target-to-background ratios of greater than or equal to 1.58, and the second was biopsy for PI-RADSv2 5 mpMRI lesions or PI-RADSv2 3-4 mpMRI lesions with 18F-choline target-to-background ratios of greater than or equal to 1.58. These strategies were compared with universal standard biopsy, mpMRI alone with biopsy only for PI-RADSv2 3-5 lesions, and mpMRI alone with biopsy only for Likert 4-5 lesions. For each mpMRI strategy, either no biopsy or standard biopsy could be performed after negative mpMRI results were obtained. Deaths averted, quality-adjusted life years (QALYs), cost, and incremental cost-effectiveness ratios were estimated for each strategy. Results: When the results of 18F-choline PET/mpMRI were negative, performing a standard biopsy was more expensive and had lower QALYs than performing no biopsy. The best screening strategy among those considered in this study performed hybrid 18F-choline PET/mpMRI with Likert scoring on men with elevated PSA, performed combined biopsy (targeted biopsy and standard 12-core biopsy) for men with positive imaging results, and no biopsy for men with negative imaging results ($22,706/QALY gained relative to mpMRI alone); this strategy reduced the number of biopsies by 35% in comparison to mpMRI alone. When the same policies were compared using PI-RADSv2 instead of Likert scoring, hybrid 18F-choline PET/mpMRI cost $46,867/QALY gained relative to mpMRI alone. In a threshold analysis, the best strategy among those considered remained cost-effective when the sensitivity and specificity of PET/mpMRI and combined biopsy (targeted biopsy and standard 12-core biopsy) were simultaneously reduced by 20 percentage points. Conclusion:18F-choline PET/mpMRI for the detection of primary prostate cancer with a Gleason score of greater than or equal to 3 + 4 is cost-effective and can reduce the number of unneeded biopsies in comparison to mpMRI alone.
Insights
Combining 18F-choline PET/multiparametric MRI (mpMRI) with targeted biopsy strategies significantly improves cost-effectiveness for detecting prostate cancer in men with elevated PSA. This approach reduces unnecessary biopsies by 35% compared to mpMRI alone.
Area of Science:
- Urology
- Radiology
- Health Economics
Background:
- Elevated prostate-specific antigen (PSA) levels in men necessitate accurate detection of primary prostate cancer (Gleason score ≥ 3 + 4).
- Multiparametric MRI (mpMRI) is a key imaging modality, but its standalone effectiveness and cost-effectiveness in conjunction with novel PET tracers require evaluation.
- Optimizing diagnostic pathways is crucial to balance detection rates, patient outcomes, and healthcare resource utilization.
Purpose of the Study:
- To evaluate the cost-effectiveness of 18F-choline PET/mpMRI compared to mpMRI alone for detecting primary prostate cancer (Gleason score ≥ 3 + 4) in men with elevated PSA.
- To assess different hybrid imaging and biopsy strategies to identify the most efficient diagnostic pathway.
- To quantify the impact on health outcomes (quality-adjusted life years - QALYs) and economic consequences.
Main Methods:
- A Markov model simulated prostate cancer onset and progression to estimate health and economic outcomes.
- Evaluated hybrid 18F-choline PET/mpMRI strategies using Likert or PI-RADSv2 scoring, incorporating targeted biopsy protocols.
- Compared these strategies against mpMRI alone with varying biopsy thresholds and universal standard biopsy protocols.
Main Results:
- Hybrid 18F-choline PET/mpMRI with Likert scoring, combined biopsy for positive imaging, and no biopsy for negative imaging, yielded a cost-effectiveness of $22,706/QALY gained relative to mpMRI alone.
- This optimal strategy reduced the number of biopsies by 35% compared to mpMRI alone.
- Using PI-RADSv2 scoring resulted in a higher cost-effectiveness ratio ($46,867/QALY gained), and threshold analysis confirmed robustness even with reduced sensitivity/specificity.
Conclusions:
- 18F-choline PET/mpMRI is a cost-effective strategy for detecting primary prostate cancer (Gleason score ≥ 3 + 4) in men with elevated PSA.
- This integrated approach significantly reduces the rate of unnecessary biopsies compared to mpMRI alone.
- The findings support the clinical utility of hybrid PET/mpMRI in optimizing prostate cancer diagnosis and resource allocation.
Related Concept Videos
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
Cancer Survival Analysis
Statistical Software for Data Analysis and Clinical Trials
Biological Effects of Radiation
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects

